Research ArticleToxicology
Octreotide Inhibits the Bilirubin Carriers Organic Anion Transporting Polypeptides 1B1 and 1B3 and the Multidrug Resistance-Associated Protein 2
Michele Visentin, Bruno Stieger, Michael Merz and Gerd A. Kullak-Ublick
Journal of Pharmacology and Experimental Therapeutics November 2015, 355 (2) 145-151; DOI: https://doi.org/10.1124/jpet.115.227546
Michele Visentin
Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Switzerland (M.V., B.S., G.A.K.-U.); and Discovery and Investigative Safety, Novartis Institutes for BioMedical Research, Basel, Switzerland (M.M., G.A.K.-U.)
Bruno Stieger
Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Switzerland (M.V., B.S., G.A.K.-U.); and Discovery and Investigative Safety, Novartis Institutes for BioMedical Research, Basel, Switzerland (M.M., G.A.K.-U.)
Michael Merz
Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Switzerland (M.V., B.S., G.A.K.-U.); and Discovery and Investigative Safety, Novartis Institutes for BioMedical Research, Basel, Switzerland (M.M., G.A.K.-U.)
Gerd A. Kullak-Ublick
Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Switzerland (M.V., B.S., G.A.K.-U.); and Discovery and Investigative Safety, Novartis Institutes for BioMedical Research, Basel, Switzerland (M.M., G.A.K.-U.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleToxicology
Octreotide and Bilirubin Carriers
Michele Visentin, Bruno Stieger, Michael Merz and Gerd A. Kullak-Ublick
Journal of Pharmacology and Experimental Therapeutics November 1, 2015, 355 (2) 145-151; DOI: https://doi.org/10.1124/jpet.115.227546
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement